Showing results (921-930 of 6,500) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Lymphocyte activation in patients with acute myeloid leukaemia. Evidence for the presence of myeloblast antigen?S H Lim, C P Worman, A H GoldstoneCancer Immunology, Immunotherapy : CII|November 12, 2013
Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?Theresa L WhitesideCancer Immunology, Immunotherapy : CII|October 12, 2013
Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functionsRaúl Germán Spallanzani, Tomás Dalotto-Moreno, Ximena Lucía Raffo Iraolagoitia, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1986
Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Classification based on phenotype, specificity and inhibition by monoclonal antibodies to T cell structuresP Hersey, M MacDonald, S Schibeci, et al.Cancer Immunology, Immunotherapy : CII|February 14, 2009
The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanomaHildur Helgadottir, Emilia Andersson, Lisa Villabona, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1991
Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with non-resectable lung cancerJ Vibe-Petersen, N Tvede, M Diamant, et al.Cancer Immunology, Immunotherapy : CII|December 3, 2008
Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse modelAsahi Ito, Takashi Ishida, Hiroki Yano, et al.Cancer Immunology, Immunotherapy : CII|December 3, 2008
Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cellsTakashi Mine, Satoko Matsueda, Yufeng Li, et al.Cancer Immunology, Immunotherapy : CII|June 2, 2010
Immunogenicity of SEREX-identified antigens and disease outcome in pancreatic cancerA Heller, I Zörnig, T Müller, et al.Cancer Immunology, Immunotherapy : CII|June 2, 2010
Pre-operative intracellular glutathione levels of peripheral monocytes as a biomarker to predict survival of colorectal cancer patientsKazuko Uno, Kiyotaka Okuno, Takuma Kato, et al.Pageof 650